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Short Communication
The prevalence of both obstructive sleep apnoea (OSA) and chronic
kidney disease (CKD) has increased significantly over the past two
decades and OSA has been identified as a frequent condition among
patients with advanced CKD [1,2], suggesting a direct association
between the two diseases.
CKD is defined as evidence of structural or functional kidney
abnormalities that persist for at least three months [3]. It affects about
10% of the adult population worldwide, and is associated with
increased cardiovascular morbidity and mortality.
Moreover, the progression of CKD to end-stage renal disease
requiring renal replacement therapy represents an enormous medical
and economic burden [4]. Currently, many efforts are made to improve
the early recognition of CKD and to retard its progression, working on
conventional risk factors such as hypertension, diabetes and obesity
[4]. Yet several other factors may contribute to the progression of renal
diseases including inflammation, hormonal factors and renal hypoxia.
Despite the identification of new mechanisms leading to renal
function decline and despite the possibility to interfere
pharmacologically with some of them (for example, blockade of the
renin-angiotensin-aldosterone system (RAS) to reduce hyper filtration
and proteinuria), CKD generally continues to progress over time.
This is probably due to unrecognized factors which play a role in the
disease progression. The role of hypoxia in the progression of renal
diseases has been intensively studied in recent years. In animal models,
hypoxia appears to play a role in CKD progression, but results in
humans are more controversial [5].
Recently, retrospective studies have suggested that intermittent
nocturnal hypoxia, a hallmark of OSA together with recurrent
respiratory events during sleep, not only increases several folds the risk
of developing a cardiovascular event (stroke, myocardial infarction…),
but may also contribute to the progression of CKD [6,7]. Yet, the real
impact of OSA on CKD progression remains poorly investigated, and
the mechanisms linking OSA and CKD progression are incompletely
understood, but may include oxidative stress, inflammation,
endothelial cell dysfunction and direct stimulation of the sympathetic
nervous system and the renin-angiotensin-aldosterone system.
In epidemiological studies, an association between OSA and
advanced CKD has been found and persists after correction for
potential confounding factors such as diabetes, hypertension and
obesity, suggesting a direct association between the two diseases [1,8].
On the other hand, a general population based study focusing on
early CKD showed an impaired sleep quality of CKD patients, but no
association between OSA and kidney function after correction for
confounders [9]. This suggests that the increased prevalence of OSA in
patients with advanced CKD may be due to factors appearing only late
in the course of kidney function decline.
Accordingly, OSA may play a greater role in the decline of kidney
function once CKD is present, than in the initiation of the kidney
disease.
In the meantime, there is some evidence that kidney failure may
promote the development of OSA and nocturnal hypoxia.
One possible mechanism of this reverse causality relationship could
be the CKD-induced fluid overload, with upper airways collapse being
amplified by overnight fluid displacement to the neck soft tissues.
Indeed, movements of fluid towards the neck have been documented
in end-stage renal disease patients with OSA [10].
Nevertheless, it is less certain whether fluid shifts occur in the
earlier stages of CKD. In addition, earlier works have shown that some
therapeutic options of kidney failure, like nocturnal haemodialysis [11]
or nocturnal peritoneal dialysis [12], improve the severity of OSA,
suggesting that factors originating from the decline of renal function
may participate in the increased prevalence of OSA in end-stage renal
disease patients.
Taken together, available data strongly suggest the existence of an
association between CKD and OSA, without addressing the direction
of neither the causal link nor the underlying pathophysiological
mechanisms in satisfactory way.
In fact, OSA may be a consequence of CKD as well as an
aggravating factor of CKD progression. We propose a bidirectional
relationship between OSA and CKD (Figure 1), and we estimate that a
better understanding of the causal relationship between OSA and renal
function is of great clinical interest: if OSA confirms to be a risk factor
for the progression of CKD, identification and treatment of OSA may
provide a potential disease-modifying intervention that could delay the
progression of kidney disease.
Such observations may be of particular interest in the light of the
actual development of drugs interfering with renal oxygen-sensing
mechanisms and interstitial fibrosis.
Journal of Sleep Disorders & Therapy Ogna and Ogna, J Sleep Disord Ther 2016, 5:3http://dx.doi.org/10.4172/2167-0277.1000245
Short Communication Open Access
J Sleep Disord Ther
ISSN:2167-0277 JSDT, An open access Volume 5 • Issue 3 • 1000245
Figure 1: Vicious circle implicating hypoxia and fluid overload in
the progression of CKD.
On the reverse side, demonstrating that CKD-related factors like
water retention contribute to the development of OSA could result in
the study of specific strategies to treat CKD-related complications (e.g.
a better management of fluid overload), allowing to break the vicious
circle of nocturnal hypoxia. Moreover, an adequate screening and
management of OSA in CKD patients may help to reduce their very
high cardiovascular risk.
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